Science Explorer Back to mapMap
Discussion
Researcher · Synageva BioPharma (United States) · United States

Radhika Tripuraneni

Radhika Tripuraneni publishes mostly in Physiology, Physiology and Pathology and Forensic Medicine, on topics such as Lysosomal Storage Disorders Research, Calcium signaling and nucleotide metabolism and Biomedical Research and Pathophysiology.

ORCID 0009-0008-6866-1100 OpenAlex
World rank
#3,193,329
of 7,710,434 ranked researchers
Rank in United States
#907,707
of 1,627,098
Works
24
Citations
368
Citations per work
15.3
h-index
7
i10-index 6Top 79% in Physiology (Medicine)
Radhika Tripuraneni

What does Radhika Tripuraneni research?

Radhika Tripuraneni's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (6%).

Health Sciences: 11 works · 45.2% of their workMedicine: 11 works · 45.2% of their workPhysiology: 7 works · 27.4% of their workPathology and Forensic Medicine: 3 works · 11.3% of their workSurgery: 2 works · 6.5% of their workLife Sciences: 7 works · 29.1% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 22.6% of their workPhysiology: 4 works · 16.1% of their workMolecular Biology: 2 works · 6.5% of their workImmunology and Microbiology: 2 works · 6.5% of their workImmunology: 2 works · 6.5% of their workEverything else: 6 works · 25.7% of their workTHEIR WORKRadhikaTripuraneni24works
Life Sciences29%Health Sciences45%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1145.2%
    1. Biochemistry, Genetics and Molecular Biology522.6%
    2. Immunology and Microbiology26.5%
  3. Everything else625.7%
  1. 1Physiology27% of their works
  2. 2Physiology16% of their works
  3. 3Pathology and Forensic Medicine11% of their works
  4. 4Molecular Biology6% of their works
  5. 5Surgery6% of their works
  6. 6Immunology6% of their works

Research topics

Which keywords describe Radhika Tripuraneni's research?

The keywords of their largest research topics: Enzyme Replacement Therapy, Lysosomal Storage Disorders, Lysosomal Calcium Signaling, Two-pore Channels, Cysteamine Therapy, Cystinosis, Genetic Variants and Piezo1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Enzyme Replacement Therapy121 topic
  2. Lysosomal Storage Disorders121 topic
  3. Lysosomal Calcium Signaling101 topic
  4. Two-pore Channels101 topic
  5. Cysteamine Therapy61 topic
  6. Cystinosis61 topic
  7. Genetic Variants52 topics
  8. Piezo141 topic
  9. Piezo241 topic
  10. Cardiac Amyloidosis31 topic
  11. Glucose-6-Phosphate Dehydrogenase Deficiency31 topic
  12. Neonatal Jaundice31 topic
  13. Transthyretin31 topic
  14. Cholesterol-lowering21 topic
  15. Statins21 topic
  16. Endocytosis11 topic
  17. Membrane Fusion11 topic

Where does Radhika Tripuraneni work?

Radhika Tripuraneni's main affiliation in the publication record is Synageva BioPharma (United States), United States.

How many publications and citations does Radhika Tripuraneni have?

OpenAlex counts 24 works and 368 citations for Radhika Tripuraneni, an h-index of 7, ranking #3,193,329 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Radhika Tripuraneni. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.